Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iBio (IBIO) Restructuring Costs (2018 - 2021)

iBio (IBIO) has disclosed Restructuring Costs for 4 consecutive years, with $61000.0 as the latest value for Q4 2021.

  • On a quarterly basis, Restructuring Costs fell 65.54% to $61000.0 in Q4 2021 year-over-year; TTM through Jun 2022 was $250000.0, a 66.4% decrease, with the full-year FY2022 number at $250000.0, down 66.4% from a year prior.
  • Restructuring Costs was $61000.0 for Q4 2021 at iBio, down from $189000.0 in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $289000.0 in Q4 2018 to a low of $61000.0 in Q4 2021.
  • A 4-year average of $196142.9 and a median of $187000.0 in 2020 define the central range for Restructuring Costs.
  • Peak YoY movement for Restructuring Costs: grew 8.19% in 2020, then plummeted 65.54% in 2021.
  • iBio's Restructuring Costs stood at $289000.0 in 2018, then plummeted by 42.91% to $165000.0 in 2019, then increased by 7.27% to $177000.0 in 2020, then tumbled by 65.54% to $61000.0 in 2021.
  • Per Business Quant, the three most recent readings for IBIO's Restructuring Costs are $61000.0 (Q4 2021), $189000.0 (Q3 2021), and $193000.0 (Q2 2021).